How EggFreezingCost.com sources, calculates, and updates cost data
What this site is and is not
- An independent cost reference focused on egg freezing in the United States, with secondary coverage of the UK, Canada, Mexico, and European fertility-tourism markets.
- Not a clinic, not a clinic-finder service, not a fertility provider.
- Not a financial advisor.
- Not a medical practice and does not provide medical advice.
Primary sources
Every dollar figure, percentage, success rate, and clinical statement on this site cites one or more of the following named primary sources. Where a figure depends on a single source, the source is cited inline at the figure. Where a figure aggregates multiple sources, the aggregation method is documented in the calculation framework section below.
| Source | Refresh cadence | What this site uses it for |
|---|---|---|
| ASRM Practice Committee Documents | Periodic guideline updates; major revisions every 3-5 years | Eggs-needed-by-age math, fertility preservation guidance, oocyte cryopreservation practice opinions. Primary source for the 9-14 / 15 / 26-plus eggs-needed-for-70%-live-birth ranges. |
| ASRM Ethics Committee Opinion (Planned Oocyte Cryopreservation, 2023) | Opinion update on policy change | Explicit no-guarantee framing on planned oocyte cryopreservation outcomes. Drives the /is-it-worth-it editorial position and the per-egg success caveat across the site. |
| SART (Society for Assisted Reproductive Technology) National Summary | Annual; preliminary data updated quarterly | Clinic-level cycle counts, retrieval and transfer outcome data, age-banded live-birth-per-retrieval rates. Cross-checked against CDC ART Surveillance for the live-birth-per-retrieval bands by age. |
| CDC ART Surveillance Annual Report | Annual (latest published with ~2-year lag) | National live-birth-per-retrieval rate by age band (under 35, 35-37, 38-40, 41-42, over 42), national cycle volume, fertility preservation cycle counts. Authoritative US national-data reference. |
| FertilityIQ Egg Freezing Cost Articles | Updated periodically; rolling clinic-data refresh | Lifetime-cost decomposition (procedure ~70%, medications ~10%, storage ~20%), national per-cycle ranges, average-patient cycle counts. Most-cited reference in the niche; cross-checked against GoodRx and Cofertility regional data. |
| Cofertility Comparing Egg Freezing Costs Across the US | Periodic refresh; published 2023 with ongoing edits | Metro-tier regional pricing (tier-1 NYC / San Francisco / Boston, tier-2 mid-tier metros, tier-3 secondary markets). Reference for the by-state per-cycle range methodology. |
| GoodRx Egg Freezing and Fertility Cost Analyses | Periodic refresh; pricing engine updated rolling | Stimulation medication cost ranges (Gonal-F, Follistim, Menopur, Cetrotide, Ovidrel) and consumer-facing price data. Cross-checked against pharmacy retail pricing. |
| CCRM Fertility Public Pricing and Clinical Content | Clinic public pricing updated rolling | Named-clinic public pricing for tier-1 metro markets (Denver, Boston, San Francisco, Houston, Minneapolis). Reference clinic for Colorado, Massachusetts, California, Texas, and Minnesota per-state pages. |
| NYU Langone Fertility Center Pricing | Public pricing updated rolling | Tier-1 NYC clinic pricing reference for the New York state page. NYU Langone, RMA of New York, Cornell, and Columbia represent the four major NYC academic-affiliated reference points. |
| HFEA UK Storage and Treatment Statistics | Annual treatment data; periodic policy reports | UK per-cycle pricing, the 2022 55-year regulatory storage cap with consent-renewal-every-10-years rule, NHS-funded versus private patterns. Primary source for the UK country page. |
| RESOLVE National Infertility Association | Updated after state legislative sessions and on bill effective dates | State insurance mandate tracking. Cross-checked against state legislative texts directly for currency (CA SB 729, GA HB 94, FL iatrogenic group-plan rule, MN HF 1758). |
| KFF (Kaiser Family Foundation) State Health Policy Data | Updated on legislative change | State infertility mandate cross-reference; women's health policy framing; insurer policy coverage analyses. |
| State Legislative Texts (Primary) | Bill text and effective dates verified directly | Direct sourcing of California SB 729, Georgia HB 94, Florida iatrogenic group-plan rule, Minnesota HF 1758, Massachusetts MGL c.175 §47H, New York Insurance Law §3221, Illinois 215 ILCS 5/356m. Avoid relying on secondary summaries for legal currency. |
| Cobo et al. 2021 - Six Years' Experience in Ovum Donation Using Vitrified Oocytes | Published 2021; no degradation observed through 14-plus years | Long-term storage outcomes for vitrified oocytes. Source for the no-degradation-with-time storage framing. |
| Goldman et al. 2017 - Oocyte Efficiency: Eggs Needed for One Live Birth | Published 2017 | Eggs-needed-for-target-live-birth math by age. Cross-referenced against ASRM 2021 evidence-based outcomes data. |
| Fertility & Sterility 2021 - Utilisation of Cryopreserved Oocytes | Published 2021 | 38.1% utilisation rate (patients returning to use frozen eggs as of 2021). Source for the implicit-fertility-insurance framing on /is-it-worth-it. |
| Named Insurer Policy Documents | Insurer policy updates periodic | Aetna, BCBS Federal Employee Programme, UnitedHealthcare, Cigna fertility preservation policies. Primary source rather than secondary summaries. |
| Extend Fertility Public Outcomes Data | Clinic outcomes data updated rolling | Per-age yield-per-cycle reference (12-18 mature eggs at 30-34, 8-14 at 35-37, 6-10 at 38-40). Single-clinic data point cross-checked against SART aggregate. |
Calculation framework
National $12,000-$20,000 all-in is the consensus range across FertilityIQ cost decomposition, GoodRx aggregate analyses, and Cofertility regional tier data. The low end represents minimal-stim and discount-chain pricing; the high end represents tier-1 metro academic-affiliated clinics. Mid-tier metros sit at $14,000-$17,000.
Each per-state range layers metro cost-of-living and clinic-concentration on the national consensus. Tier-1 metros (NYC, San Francisco, Boston) sit at $15,000-$24,000; tier-2 metros (Chicago, Denver, Seattle, Philadelphia) at $12,000-$18,000; tier-3 metros (Phoenix, Tampa, Atlanta, Charlotte) at $10,000-$15,000. Named clinic public pricing is the third triangulation point per state.
ASRM eggs-needed-for-70%-live-birth: 9-14 mature eggs at 30-34, ~15 at 35-37, 26-plus at 38-40. Average yield per cycle (Extend Fertility outcomes data cross-checked against SART): 12-18 mature eggs at 30-34, 8-14 at 35-37, 6-10 at 38-40. Expected cycles per target: 1 cycle under 35, 1-2 cycles 35-37, 2-3 cycles 38-40, 3-plus cycles over 40.
Annual storage fee $500-$1,000 at US clinics, $1,500 at tier-1 academic, $200-$500 at off-site cryostorage (ReproTech, MyEggBank, Fairfax Cryobank). Year one usually included in the cycle price. 10-year cumulative at $750 / year for 9 paid years is $6,750. Storage represents roughly 20% of lifetime egg-freezing cost per FertilityIQ decomposition.
Per use-attempt: thaw ($1,000-$2,500), ICSI fertilisation ($1,500-$3,000), embryo transfer ($3,000-$5,500), monitoring ($300-$800). $5,800-$11,800 per attempt; most patients budget two attempts. Per-egg success roughly 6-7% on average per mature egg, varying with freeze age. Lifecycle total typically $30,000-$50,000 across the freeze, storage, and use phases.
State insurance mandate detail is sourced directly from state legislative texts (CA SB 729, GA HB 94, FL iatrogenic group-plan rule, MN HF 1758, MA c.175 §47H, NY §3221, IL 215 ILCS 5/356m, CO Building Families Act). Cross-checked against RESOLVE and KFF tracking. Insurer policy positions (Aetna, BCBS-FEP, UHC, Cigna) sourced from published policy documents, not secondary summaries.
In scope
- National 2026 per-cycle cost range for the United States.
- Per-state per-cycle ranges for the 12 highest-population states with the highest fertility-clinic concentration.
- UK private pricing, Canada provincial coverage, Mexico fertility-tourism pricing, and Czech / Spain / Greece comparative pricing.
- Component breakdown (procedure, medications, monitoring, storage, lifecycle).
- Age x cost x cycle interaction via ASRM eggs-needed and SART / CDC live-birth data.
- State insurance mandates and major insurer fertility-preservation policies.
- Storage-fee cumulative math (5-year, 10-year, 15-year).
- Lifecycle cost (freeze + store + thaw + IVF + transfer).
- Employer-benefit landscape (Carrot, Progyny, Maven, WIN Fertility) at general framing.
- Fertility-financing options (CapexMD, Future Family, EggFund, Sunfish, CareCredit, prosper).
Out of scope
- Individual veterinary or medical diagnosis (not a medical practice).
- Specific clinic quotes for a specific patient or treatment plan (always confirm with the clinic).
- Detailed coverage of countries outside US / UK / Canada / Mexico / EU fertility-tourism markets.
- Specific employer fertility benefit policy decoding (varies per plan).
- Off-label medication use or non-standard stimulation protocols.
- Embryo-freezing-specific cost math beyond the lifecycle page's IVF + transfer component.
- Surrogacy, gestational carrier, or donor egg cost (different cost surface, different sites).
Refresh cadence
Single source of truth: one LAST_VERIFIED_DATE constant in src/lib/schema.ts drives every date stamp on the site (footer, disclaimer band, verified-stamp on every page, WebSite schema dateModified, Article dateModified, MedicalWebPage dateModified). Currently set to June 2026.
Verification cadence is at least every six months for cost data; quarterly for named clinic public pricing; immediately after each state legislative session ends or a flagged bill takes effect. Out-of-cycle refresh triggers:
- New ASRM practice committee document, evidence-based outcomes update, or ethics opinion.
- New CDC ART Surveillance report (annual).
- New state insurance mandate effective date (CA SB 729 January 2026; GA HB 94 January 2026; MN HF 1758 January 2026).
- Named insurer policy change affecting fertility preservation (Aetna, BCBS, UHC, Cigna).
- Major clinic chain pricing change at a triangulation reference (CCRM, NYU Langone, RMA, Shady Grove).
- New peer-reviewed cohort on long-term outcomes, utilisation, or per-egg success.
Limitations
- Cost ranges are estimates synthesised from named primary sources; they are not individual quotes for a specific patient or clinic.
- FertilityIQ cost decomposition reflects survey data with respondent-recall and self-selection caveats; cross-checked against GoodRx and Cofertility.
- SART and CDC ART Surveillance live-birth-per-retrieval rates aggregate across clinics with very different patient populations; individual clinic outcomes vary.
- ASRM eggs-needed math is probabilistic, not deterministic; "70% chance of one live birth" is a target, not a guarantee.
- Per-state ranges may not reflect the very low end (university clinical-trial discounts) or the very high end (concierge / out-of-network).
- International pricing in USD reflects exchange rates at last verification; revisit before relying on currency-comparison figures.
- Calculator outputs always show their assumptions inline.
Conflict-of-interest disclosure
This site is operated as part of the Digital Signet network of independent cost references. Monetisation methods include display advertising (premium health network) with non-clinical-fertility advertiser blocklists where technically possible, and honest-comparison framing for named fertility-specific lenders (Future Family, EggFund, Sunfish) and CareCredit where their published terms are referenced. Where employer fertility benefit platforms run affiliate programmes, the framing is honest comparison rather than a lead-gen funnel.
Explicit non-monetisation choices:
- No clinic affiliate links (treated as a structural conflict in this niche).
- No clinic-finder placements or "get a quote near you" widgets.
- No sponsored content.
- No paid placements from vaccine, medication, or device manufacturers.
- No "free egg freezing in exchange for donating" partnerships.
Editorial standards
- Third-person reference voice. No first-person operator phrasing.
- No em-dashes anywhere. Use commas, colons, parentheses, or sentence splits.
- No medical advice framing. Always informational.
- No predatory urgency framing.
- "Consult a board-certified reproductive endocrinologist" callouts at every decision-relevant point.
- Calculator outputs always show their assumptions inline.
- Tone: editorial-warm, primary-sourced, neutral, transparent, slightly underselling rather than overselling.
Corrections process
Suggest a correction, update, or new source via the Digital Signet parent site. Include the URL of the page in question, the specific claim that needs review, the source you believe should be referenced, and any verification date. Verified corrections are published with a date stamp and source citation update, typically within 5 business days. Material data changes (a band shift of 10% or more) roll the LAST_VERIFIED_DATE forward across footer, schema, and date-stamp surfaces in a single commit.
Medical disclaimer
EggFreezingCost.com is an independent cost-reference resource. It is not a medical practice and does not provide medical advice. Egg freezing is a significant medical and financial decision. Always consult a board-certified reproductive endocrinologist for personalised guidance. Pricing data is aggregated from publicly available clinic listings, peer-reviewed research, and regulatory sources, and may not reflect individual clinic quotes or your specific case.